Article Details
Retrieved on: 2018-03-02 04:59:59
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
<div>Roche's acquisition of <b>Flatiron Health</b> signals the pharmaceutical industry's interest in using real-world data to measure value, said Brigham Hyde, CEO and founder of Precision Health AI, a company that uses artificial intelligence to define cancer datasets for precision oncology. “If I were a ...</div>
Article found on:
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here